Trend
โ
Key levels
โ
Latest news & SEC filings
No headlines in the last 90 days.
ยท Healthcare
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for APLT.
Start Free Trial โValuation Verdict
UNDERVALUED
Methods Used
P/B, PEG
Fair Value
$0.54
5
Moat Score
NONE
1/9
Piotroski Score
-35.3
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Insider trades, congress trades, institutional flows, and short interest โ updated daily with real-time alerts.
See All Smart Money Signals โRevenue YoY
-95.5%
3yr Revenue CAGR
N/A%
EPS Growth YoY
46.48%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
SEPT's Trading AI has generated a free, downloadable PDF research report for Applied Therapeutics, Inc. (APLT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days โApplied Therapeutics, Inc. (APLT) is at $0.10, up 0.19% (+$0.00) at the Feb 2, 2026 close.
APLT last reported on Nov 13, 2025: EPS -$0.13 vs -$0.14 expected โ a beat of 7.8%.
APLT does not currently pay a dividend.
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.